Tyra Biosciences, Inc. NASDAQ:TYRA

Founder-led company

Tyra Biosciences stock price today

$10.1
-3.97
-28.22%
Financial Health
0
1
2
3
4
5
6
7
8
9

Tyra Biosciences stock price monthly change

-28.98%
month

Tyra Biosciences stock price quarterly change

-28.98%
quarter

Tyra Biosciences stock price yearly change

+0.50%
year

Tyra Biosciences key metrics

Market Cap
723.28M
Enterprise value
357.88M
P/E
-10.97
EV/Sales
N/A
EV/EBITDA
-4.42
Price/Sales
N/A
Price/Book
2.35
PEG ratio
-0.10
EPS
-1.68
Revenue
N/A
EBITDA
-87.54M
Income
-75.44M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Tyra Biosciences stock price history

Tyra Biosciences stock forecast

Tyra Biosciences financial statements

Average Price Target
Last Year

$30.4

Potential upside: 200.99%

Based on estimate of 4 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Tyra Biosciences, Inc. (NASDAQ:TYRA): Profit margin
Jun 2023 0 -13.27M
Sep 2023 0 -21.15M
Dec 2023 502K -22.83M -4547.81%
Mar 2024 0 -18.19M
Tyra Biosciences, Inc. (NASDAQ:TYRA): Earnings per share (EPS)
2024-03-19 -0.48 -0.53
2024-05-09 -0.46 -0.35
Tyra Biosciences, Inc. (NASDAQ:TYRA): Debt to assets
Jun 2023 250012000 11.44M 4.58%
Sep 2023 238358000 16.18M 6.79%
Dec 2023 225857000 21.59M 9.56%
Mar 2024 404741000 14.86M 3.67%
Tyra Biosciences, Inc. (NASDAQ:TYRA): Cash Flow
Jun 2023 -9.61M -43K 370K
Sep 2023 -17.14M -83K 467K
Dec 2023 -13.53M -144.43M 324K
Mar 2024 -22.02M 18.07M 200.31M

Tyra Biosciences alternative data

Tyra Biosciences, Inc. (NASDAQ:TYRA): Employee count
Aug 2023 38
Sep 2023 38
Oct 2023 38
Nov 2023 38
Dec 2023 38
Jan 2024 38
Feb 2024 38
Mar 2024 49
Apr 2024 49
May 2024 49
Jun 2024 49
Jul 2024 49

Tyra Biosciences other data

27.08% -56.83%
of TYRA is owned by hedge funds
11.34M -23.89M
shares is hold by hedge funds

Tyra Biosciences, Inc. (NASDAQ:TYRA): Insider trades (number of shares)
Period Buy Sel
Feb 2024 0 190806
Jun 2024 0 3702
Sep 2024 0 28554
Oct 2024 9500 232664
Nov 2024 1220681 118916
Transaction Date Insider Security Shares Price per share Total value Source
Sale
KJELLSON NINA S director
Common Stock 4,706 $16.84 $79,244
Sale
KJELLSON NINA S director
Common Stock 566 $16.84 $9,531
Purchase
RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner:
Common Stock 1,220,681 $16.25 $19,836,066
Sale
KJELLSON NINA S director
Common Stock 19,720 $17.32 $341,511
Sale
KJELLSON NINA S director
Common Stock 2,371 $17.32 $41,061
Sale
KJELLSON NINA S director
Common Stock 46,856 $17.18 $804,799
Sale
KJELLSON NINA S director
Common Stock 5,635 $17.18 $96,787
Sale
KJELLSON NINA S director
Common Stock 9,367 $16.77 $157,066
Sale
KJELLSON NINA S director
Common Stock 1,126 $16.77 $18,881
Sale
KJELLSON NINA S director
Common Stock 960 $17.01 $16,326
Insider Compensation
Dr. Todd Harris Ph.D. (1979) Pres, Chief Executive Officer, Sec., Treasurer & Director
$561,330
Mr. Daniel Bensen (1974) Co-Founder & Chief Operating Officer
$374,440
Dr. Ronald V. Swanson Ph.D. (1963) Chief Scientific Officer
$358,720
Sunday, 17 November 2024
247wallst.com
Wednesday, 13 November 2024
prnewswire.com
Thursday, 7 November 2024
prnewswire.com
Monday, 28 October 2024
prnewswire.com
Friday, 25 October 2024
benzinga.com
Thursday, 24 October 2024
prnewswire.com
Wednesday, 23 October 2024
prnewswire.com
Monday, 21 October 2024
seekingalpha.com
Friday, 18 October 2024
benzinga.com
Friday, 11 October 2024
prnewswire.com
Thursday, 12 September 2024
accesswire.com
Wednesday, 11 September 2024
prnewswire.com
accesswire.com
Tuesday, 10 September 2024
prnewswire.com
accesswire.com
Monday, 9 September 2024
accesswire.com
zacks.com
Saturday, 7 September 2024
accesswire.com
Friday, 6 September 2024
accesswire.com
Thursday, 5 September 2024
accesswire.com
Wednesday, 4 September 2024
accesswire.com
Monday, 2 September 2024
accesswire.com
Sunday, 1 September 2024
accesswire.com
Saturday, 31 August 2024
accesswire.com
Friday, 30 August 2024
accesswire.com
Thursday, 29 August 2024
accesswire.com
Wednesday, 28 August 2024
accesswire.com
Tuesday, 27 August 2024
accesswire.com
accesswire.com
Monday, 26 August 2024
accesswire.com
  • What's the price of Tyra Biosciences stock today?

    One share of Tyra Biosciences stock can currently be purchased for approximately $10.1.

  • When is Tyra Biosciences's next earnings date?

    Unfortunately, Tyra Biosciences's (TYRA) next earnings date is currently unknown.

  • Does Tyra Biosciences pay dividends?

    No, Tyra Biosciences does not pay dividends.

  • How much money does Tyra Biosciences make?

    Tyra Biosciences has a market capitalization of 723.28M. Tyra Biosciences made a loss 69.13M US dollars in net income (profit) last year or -$0.35 on an earnings per share basis.

  • What is Tyra Biosciences's stock symbol?

    Tyra Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "TYRA".

  • What is Tyra Biosciences's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Tyra Biosciences?

    Shares of Tyra Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Tyra Biosciences's key executives?

    Tyra Biosciences's management team includes the following people:

    • Dr. Todd Harris Ph.D. Pres, Chief Executive Officer, Sec., Treasurer & Director(age: 46, pay: $561,330)
    • Mr. Daniel Bensen Co-Founder & Chief Operating Officer(age: 51, pay: $374,440)
    • Dr. Ronald V. Swanson Ph.D. Chief Scientific Officer(age: 62, pay: $358,720)
  • Is Tyra Biosciences founder-led company?

    Yes, Tyra Biosciences is a company led by its founder Mr. Daniel Bensen.

  • How many employees does Tyra Biosciences have?

    As Jul 2024, Tyra Biosciences employs 49 workers.

  • When Tyra Biosciences went public?

    Tyra Biosciences, Inc. is publicly traded company for more then 3 years since IPO on 15 Sep 2021.

  • What is Tyra Biosciences's official website?

    The official website for Tyra Biosciences is tyra.bio.

  • Where are Tyra Biosciences's headquarters?

    Tyra Biosciences is headquartered at 2656 State Street, Carlsbad, CA.

  • How can i contact Tyra Biosciences?

    Tyra Biosciences's mailing address is 2656 State Street, Carlsbad, CA and company can be reached via phone at +61 97284760.

  • What is Tyra Biosciences stock forecast & price target?

    Based on 4 Wall Street analysts` predicted price targets for Tyra Biosciences in the last 12 months, the avarage price target is $30.4. The average price target represents a 200.99% change from the last price of $10.1.

Tyra Biosciences company profile:

Tyra Biosciences, Inc.

tyra.bio
Exchange:

NASDAQ

Full time employees:

49

Industry:

Biotechnology

Sector:

Healthcare

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.

2656 State Street
Carlsbad, CA 92008

CIK: 0001863127
ISIN: US90240B1061
CUSIP: 90240B106